Postbiotics are defined as bioactive compounds produced by the fermentation of probiotics. Unlike probiotics, which are live microorganisms, postbiotics comprise a variety of metabolites, including short-chain fatty acids, peptides, and polysaccharides. These metabolites possess biological activity and are thought to contribute positively to gut health and overall metabolic function. The idea that non-living entities can exert beneficial effects on health challenges previously held beliefs about the role of live bacteria in maintaining homeostasis in the body.

The search for effective measures against obesity is both urgent and significant. The World Health Organization has categorized obesity as a global epidemic, cementing its ties to a host of non-communicable diseases, including type 2 diabetes, cardiovascular disease, and certain cancers. The complexity of obesity as a condition is compounded by genetic, environmental, and behavioral factors, making traditional approaches to weight loss less effective for some individuals. Thus, innovative solutions such as postbiotics present exciting opportunities for new treatment paradigms.

In his exhaustive review, Khodarahmi delves into a substantial corpus of animal studies that highlight the mechanisms through which postbiotics may facilitate weight loss and enhance metabolic health. One of the most compelling findings from these studies is the role of postbiotics in modulating gut microbiota. The balance of gut bacteria plays a crucial role in metabolic processes; a diverse and healthy microbiome can aid in the breakdown of nutrients and contribute to energy expenditure. Conversely, dysbiosis—an imbalance in gut flora—has been linked to obesity and metabolic disorders.

Moreover, postbiotics appear to exert anti-inflammatory effects that significantly impact the metabolic syndrome. Chronic inflammation is often present in obese individuals, contributing to insulin resistance and metabolic dysfunction. By reducing systemic inflammation, postbiotics could help mitigate some of the adverse health effects associated with excess body weight. This inflammation-reducing property is particularly vital as it aligns with the growing recognition that inflammation is not merely a symptom but a core contributor to metabolic diseases.

Additionally, the data compiled by Khodarahmi indicates that postbiotics may enhance lipid metabolism as well. Studies detailed in the review demonstrate that certain postbiotic compounds can regulate lipid profiles by lowering triglycerides and LDL cholesterol levels. This lipid-modulating effect is critical for improving cardiovascular outcomes, especially in individuals struggling with obesity, where the risk of atherosclerosis and other lipid-related diseases is significantly elevated.

Importantly, the research also sheds light on the behavioral aspects associated with postbiotic consumption. Animal studies indicate that the intake of postbiotics may influence appetite regulation, potentially leading to decreased caloric intake. This appetite-suppressing effect opens new avenues for understanding how microbiota-derived compounds can affect the central nervous system and, consequently, eating behaviors. The intersection of gut health and neurobiology in obesity management highlights a multifaceted approach to treatment that could be more effective than conventional methods.

The systematic review not only compiles evidence supporting the efficacy of postbiotics, but it also addresses potential concerns associated with their use. For instance, it is important to consider the source and type of postbiotics, as the biological effects can vary significantly. The authors emphasize the necessity of standardizing postbiotic formulations for consistent clinical applications, as well as the importance of conducting further research to isolate which specific types of postbiotics are most beneficial for obesity management.

Despite the promising nature of postbiotics, it is crucial to contextualize these findings within the broader landscape of obesity treatment. Several interventions, including lifestyle modifications, pharmacotherapy, and surgical options, have so far yielded varied outcomes. Importantly, the integration of postbiotic therapies into existing treatment frameworks may enhance the overall effectiveness of obesity management strategies, ultimately benefiting patient outcomes.

Khodarahmi’s review does not shy away from highlighting the limitations of the current body of research. Much of it is derived from animal studies, and although these provide invaluable insights, they do not always translate directly to human health outcomes. Consequently, the author calls for rigorous clinical trials to evaluate the efficacy of postbiotics in humans. Such studies are essential for determining optimal dosages and assessing long-term safety and efficacy.

The implications of this research extend well beyond the individual level, potentially reshaping public health strategies aimed at addressing obesity. With traditional methods often falling short, the integration of postbiotics into public health frameworks could not only lead to a decrease in obesity rates but also foster a more comprehensive approach to metabolic health at a population level.

Moreover, as the conversation around gut health continues to gain traction in wellness and clinical settings alike, postbiotics could serve as essential components in functional foods and supplements aimed at obesity intervention. This could create a burgeoning market that not only addresses health trends but promotes overall well-being.

In conclusion, the systematic review and meta-analysis spearheaded by M. Khodarahmi signify a critical advancement in the understanding of obesity management through postbiotics. As we transition from theory to practice in the realm of metabolic health, this body of work serves as a clarion call for further exploration into these unconventional agents. The therapeutic applications of postbiotics could very well herald a new chapter in the fight against obesity, making strides toward a healthier society.

Subject of Research: Postbiotics as an intervention for obesity management

Article Title: Letter to Editor: Postbiotics as a novel intervention for obesity management and improving metabolic parameters: a systematic review and meta-analysis of animal studies

Article References:

Khodarahmi, M. Letter to Editor: Postbiotics as a novel intervention for obesity management and improving metabolic parameters: a systematic review and meta-analysis of animal studies.
J Transl Med 23, 1172 (2025). https://doi.org/10.1186/s12967-025-07127-5

Image Credits: AI Generated

DOI:

Keywords: postbiotics, obesity management, metabolic health, systematic review, animal studies, gut microbiota, inflammation, appetite regulation, lipid metabolism.

Quantification stands at the heart of postbiotic research and product development. With probiotics, scientists and manufacturers have long relied upon colony forming units (CFU) to estimate viable bacteria counts, a straightforward metric grounded in microbiological culture methods. However, postbiotics defy this simple approach given that the microbes they contain are no longer alive, rendering CFU analysis inapplicable. This fundamental challenge complicates efforts to standardize dosages, compare findings across studies, and ensure reproducibility in manufacturing processes.

Recognizing this critical gap, an international consortium of fifteen leading scientists from academia and industry collaborated under the auspices of the International Scientific Association for Probiotics and Prebiotics (ISAPP) to develop a pragmatic framework for postbiotic quantification. Their groundbreaking paper, published in Frontiers in Nutrition, addresses the urgent need for harmonized methodologies adaptable to the diverse nature of postbiotic products. This publication marks a significant milestone toward unifying the field and propelling research and industry innovation forward.

Rather than prescribing a rigid, one-size-fits-all quantification protocol, the expert collective presents a dynamic decision tree designed to guide researchers and manufacturers in selecting the most appropriate analytical techniques. This flexible framework considers critical variables such as the specific types of microorganisms involved, the degree of cell integrity, and the number of strains present in the formulation. Such a tailored approach reflects the heterogeneous and multifaceted nature of postbiotic preparations, which often comprise a complex blend of dead cells, cell fragments, and metabolic byproducts.

The complexity inherent in postbiotic compositions means that fully characterizing and quantifying every component may not always be feasible. Instead, the proposed framework encourages a strategic focus on key elements within the mixture that are most relevant to biological activity and product consistency. Ultimately, this strategy enables robust quality control, ensuring batch-to-batch reproducibility and fostering consumer confidence in postbiotic products.

Dr. Gabriel Vinderola, the first author and a distinguished microbiologist based at the National University of Littoral and CONICET in Argentina, emphasized the necessity of this initiative. He noted that following the establishment of the postbiotic definition in 2021, ongoing discourse among experts revealed an urgent demand for a standardized quantification framework to accelerate progress across scientific, regulatory, and industrial sectors. The publication aims to bridge this divide, providing practical guidance that encourages alignment and clarity in postbiotic measurement practices worldwide.

From an industrial perspective, the framework offers an invaluable resource that integrates cutting-edge technologies to quantify postbiotic components effectively. Techniques such as flow cytometry and polymerase chain reaction (PCR) are highlighted as promising tools that not only provide detailed insights into cellular integrity and genetic material but also cater to scalability and precision required in commercial settings. This synergy between advanced scientific instrumentation and practical industry needs reflects the paper’s forward-looking approach.

Moreover, the authors acknowledge that as scientific methodologies evolve, so will best practices for postbiotic quantification. The decision tree and associated guidance represent a living framework, adaptable to future technological breakthroughs and enhanced understanding of postbiotic mechanisms. This flexible orientation ensures relevance and applicability, fostering an ecosystem of continuous improvement and innovation within the field.

The impact of this publication extends beyond quantification alone. By elucidating a scientific and regulatory pathway for defining and measuring postbiotics, it sets a foundational benchmark that can stimulate investment, catalyze product development, and underpin evidence-based claims in the marketplace. This structured clarity is essential not only for researchers but also for regulators and consumers navigating this emerging frontier of microbiome science.

Importantly, the paper underscores that quantity alone does not equate to efficacy—a nuanced perspective that champions a comprehensive characterization of postbiotic preparations, considering biological activity and mechanistic understanding alongside measurement. This holistic approach aligns with growing appreciation within microbiome research that function and composition are tightly interwoven in determining health outcomes.

As postbiotic research continues to expand, this expert framework is poised to become the touchstone for future studies, reinforcing robust scientific standards and fostering global harmonization. The collaboration exemplifies the power of interdisciplinary dialogue in addressing complex challenges and pioneering pathways toward novel health interventions grounded in microbiome science.

In conclusion, the advancement of postbiotic quantification represents a pivotal step in unlocking their full potential as therapeutic and preventive agents. The ISAPP-led expert working group has provided the field with a pragmatic, scientifically sound framework designed to navigate the inherent complexities of these preparations. As laboratory technologies and industry standards evolve, the foundation laid by this consensus will undoubtedly support the responsible development, characterization, and commercialization of postbiotics worldwide, ushering in a new era of microbiome-based innovation.

Subject of Research: Not applicable

Article Title: Postbiotics: a perspective on their quantification

News Publication Date: 3-Jun-2025

Web References:
https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1582733/full

References:
Vinderola G, et al. Postbiotics: a perspective on their quantification. Frontiers in Nutrition. 2025.

Keywords: Human health